Home / Drug shortages / Palivizumab Injection

Palivizumab Injection — FDA Drug Shortage

To Be Discontinued — Swedish Orphan Biovitrum AB

The FDA lists a drug shortage record for Palivizumab Injection (injection) from Swedish Orphan Biovitrum AB with status To Be Discontinued. The shortage was first posted on 08/13/2025.

Shortage Details

Status
To Be Discontinued
Company
Swedish Orphan Biovitrum AB
Package NDC
66658-231-01
Dosage Form
Injection
Presentation
Synagis, Injection, 100 mg/1 mL (NDC 66658-231-01)
Initial Posting
08/13/2025
Revised Date

FDA data resources